BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6121578)

  • 1. Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro.
    Hallengren B; Forsgren A; Melander A
    Br J Clin Pharmacol; 1982 Apr; 13(4):543-6. PubMed ID: 6121578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.
    Nakasone J; Kato T; Noguchi K; Nagamine F; Sakanashi M
    Jpn J Pharmacol; 1988 Aug; 47(4):387-95. PubMed ID: 2903263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.
    Whyte K; Jones CR; Howie CA; Deighton N; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1987; 32(3):237-43. PubMed ID: 2885202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lymphocyte capping and transformation by propranolol and related compounds.
    Anderton BH; Axford JS; Cohn P; Marshall NJ; Shen L; Sprake S
    Br J Pharmacol; 1981 Jan; 72(1):69-74. PubMed ID: 6112036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazepam/beta-adrenoceptor antagonist interactions.
    Hawksworth G; Betts T; Crowe A; Knight R; Nyemitei-Addo I; Parry K; Petrie JC; Raffle A; Parsons A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):69S-76S. PubMed ID: 6146341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of propranolol on lymphocyte rosette formation and response to plant mitogens.
    Dunne JV; Peters CJ; Moore TL; Vaughan JH
    Arthritis Rheum; 1978; 21(7):767-73. PubMed ID: 697947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
    Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
    Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by propranolol of 3,5,3'-triiodothyronine formation from thyroxine in isolated rat renal tubules: an effect independent of beta-adrenergic blockade.
    Heyma P; Larkins RG; Campbell DG
    Endocrinology; 1980 May; 106(5):1437-41. PubMed ID: 6102511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thyroid function and size in healthy man during 3 weeks treatment with beta-adrenoceptor-antagonists.
    Kayser L; Perrild H; Feldt-Rasmussen U; Hegedüs L; Skovsted L; Hansen JE
    Horm Metab Res; 1991 Jan; 23(1):35-7. PubMed ID: 1673110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment.
    Michel MC; Pingsmann A; Beckeringh JJ; Zerkowski HR; Doetsch N; Brodde OE
    Br J Pharmacol; 1988 Jul; 94(3):685-92. PubMed ID: 2902891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing.
    Romana-Souza B; Santos JS; Monte-Alto-Costa A
    Wound Repair Regen; 2009; 17(2):230-9. PubMed ID: 19320892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway.
    Nicholson AN; Wright NA; Zetlein MB; Currie D; McDevitt DG
    Br J Clin Pharmacol; 1988 Aug; 26(2):129-41. PubMed ID: 2905149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor antagonists and human sperm motility.
    Curtis-Prior PB; Gadd AL
    J Pharm Pharmacol; 1990 Mar; 42(3):220-2. PubMed ID: 1974626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.